Search

everythinglearnresearchcommunity

for

Search:↓

Amyloid proteins can cause rare hair loss by depositing in the scalp.

Low-dose oral minoxidil may help with symptoms and hair regrowth in lichen planopilaris without serious side effects.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Wearing fire helmets may worsen lichen planopilaris in firefighters.

Lichen planopilaris in men often affects the scalp, eyebrows, arms, legs, and beard, with many having family members with hair loss.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Most injecting drug users in the study had hepatitis C and skin problems, which moderately affected their quality of life.

Etanercept may not prevent alopecia areata from coming back.

Excision with primary closure is an excellent treatment for extensive acne keloidalis nuchae.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Low-frequency skin massage helps nanoparticles penetrate hair follicles better.

The treatment improved hair growth in people with male pattern baldness.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Zinc is important for skin health, and supplements can help treat various skin and hair disorders, but more research is needed for conditions like psoriasis and vitiligo.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Adipose tissue-derived exosomes may help treat lichen planopilaris and preserve hair.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.